AI Identifies Noncancerous Thyroid Nodules on Ultrasound Images and Reduces Biopsies
|
By HospiMedica International staff writers Posted on 13 Jun 2022 |

Thyroid nodules are very common. Fine needle aspiration biopsy is used to diagnose thyroid cancer. However most biopsies produce benign (non-cancerous) results and are potentially avoidable. Now, a new study has found that artificial intelligence (AI) can be used to identify thyroid nodules seen on thyroid ultrasound that are very unlikely to be cancerous, reducing a large number of unnecessary biopsies.
In the new study, researchers at the University of Colorado Anschutz Medical Campus (Aurora, CO, USA) used machine learning, a type of AI, to analyze ultrasound images of thyroid nodules. Machine learning is the process of using mathematical models of data to help a computer learn without direct instruction. More than 30,000 images from 621 thyroid nodules were used to train the machine-learning model that classifies thyroid nodules as “cancer” or “no cancer.” The model was tested on a different set of 145 nodules collected at another healthcare system. The AI-based model achieved a sensitivity (ability to not miss cancer) of 97%, and a specificity (ability to correctly identify a cancer) of 61%.
“This study demonstrates that the ultrasound-based AI classifier of thyroid nodules achieves sensitivity comparable to that of thyroid biopsy with fine needle aspiration,” said study lead researcher Nikita Pozdeyev, M.D., Ph.D., of the University of Colorado Anschutz Medical Campus.
“We believe this is a good next step to improving patient care and avoiding unnecessary procedures,” he said. He noted that prospective clinical trials are needed before this tool can be accepted as a standard of care.
“We demonstrated that using AI analysis of ultrasound images to rule out thyroid cancer and avoid biopsy is definitely possible,” he said. “This technology could assist radiologists and endocrinologists in choosing which thyroid nodules should undergo biopsy, especially those in the community who may not review a large number of thyroid ultrasound images.”
Related Links:
University of Colorado Anschutz Medical Campus
Latest Critical Care News
- Wearable Robotic Gait Training Linked to Improved Walking Distance in ALS
- Consumer Smartwatch May Expand Access to Obstructive Sleep Apnea Screening
- Proposed Risk Score Prioritizes Sickest Patients for Heart Transplant
- Wristwatch Sensor Tracks Sodium and Potassium in Sweat in Real Time
- Smart Tear Sensors May Help Detect Shifts in Eye Health Over Time
- Wearable Smart Ring Receives FDA Clearance for Noninvasive Blood Oxygen Monitoring
- AI Tool Combining ECG and Blood Tests Reduces Unnecessary Heart Transplant Biopsies
- Deep Brain Stimulation Window May Matter for Parkinson’s Patients With GBA1 Variants
- Minimally Invasive Ultrasound-Guided Procedure Eases Carpal Tunnel Symptoms
- FDA-Approved App Enables Pulmonary Pressure Monitoring and Medication Guidance in Heart Failure
- Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery
- Standardized Scoring Tool Supports ICU Discharge Decisions
- Battery-Free Wearable Sensor Enables Activity Recognition for Health Monitoring
- New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction
- Noninvasive AI Tool Maps Atrial Cardiomyopathy to Support Ablation Planning
- Nasal Spray Provides Rapid Pain Relief for Children in Emergency Care
Channels
Artificial Intelligence
view channel
Optical Imaging System Helps Predict Chemotherapy Response in Cancer
Selecting chemotherapy can be difficult because tumors from different patients may respond differently to the same drug. Testing treatment effects directly on living tumor tissue could help clinicians... Read more
AI Tool Predicts Long-Term Cardiovascular Risk from Sleep Study ECG
Sleep disorders such as insomnia and obstructive sleep apnea are established cardiovascular risk factors and are commonly evaluated with overnight polysomnography. These studies routinely record electrocardiogram... Read more
Predictive Model Supports Growth Hormone Treatment Planning in Idiopathic Short Stature
Idiopathic short stature (ISS) describes children whose height is substantially below the expected range for age and sex without an identifiable medical cause. Recombinant growth hormone therapy can support... Read moreCritical Care
view channel
Proposed Risk Score Prioritizes Sickest Patients for Heart Transplant
Donor hearts remain extremely scarce in the U.S. transplant system, with one in five candidates dying or being removed from the waiting list before receiving an organ. Current allocation rules may also... Read more
Wearable Robotic Gait Training Linked to Improved Walking Distance in ALS
Amyotrophic lateral sclerosis (ALS) is a progressive neuromuscular disease that damages nerve cells controlling voluntary muscles. As the disease advances, patients can lose the ability to walk, speak,... Read moreSurgical Techniques
view channel
New Surgical Technique Enlarges Aortic Root for Larger Valve Implantation
When replacing a diseased aortic valve, a small aortic root can prevent surgeons from implanting a prosthesis large enough for the patient’s body size. This can lead to patient-prosthesis mismatch, causing... Read moreFDA Approval Expands Bridging Stent Use in Complex Aortic Aneurysm Repair
Complex aortic aneurysms are increasingly treated with fenestrated and branched endovascular aortic repair, which rely on bridging stents to maintain blood flow to visceral arteries. These complex procedures... Read morePatient Care
view channel
AI Platform Personalizes Support Between Visits for Cancer Survivors
Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more
At-Home Neuromodulation Shows Promise in Selected Patients With Hypertension
High blood pressure is a major risk factor for cardiovascular disease, including heart attack and stroke. Many patients receiving treatment for hypertension still remain above recommended blood pressure... Read more
EHR Model Flags High-Risk Periods in Patients with Metastatic Breast Cancer
Determining when patients with metastatic breast cancer are nearing the end of life remains difficult, often leading to intensive interventions with limited benefit. Prognostic uncertainty can delay goals-of-care... Read moreHealth IT
view channel
EHR Alerts Support Dosing, Sedation, and Shock Recognition in Cardiac Care
Electronic health record alerts can add to clinician workload when they are poorly targeted. In critical cardiac care, however, delayed decisions can affect treatment timing, sedation exposure, and escalation... Read more
Adaptive Radiation QA Software Gains Validation for NeoArc Treatments
Adaptive radiation therapy allows clinicians to adjust treatment plans to daily anatomical changes such as tumor shrinkage, weight loss, or organ movement, improving precision while limiting exposure to... Read morePoint of Care
view channel
Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes
Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Microneedle Patch Enables At-Home Monitoring of Acute Kidney Injury
Kidney disease is often silent in its early stages, making timely detection difficult outside clinical settings. Early biomarkers such as neutrophil gelatinase–associated lipocalin can require blood draws... Read moreBusiness
view channel
Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal
Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Stryker Enters Soft-Tissue Robotics Through Strategic Alliance With CMR Surgical
Stryker (Portage, MI, USA) and CMR Surgical (Cambridge, UK) have announced a strategic alliance centered on the Versius Surgical Robotic portfolio. The agreement includes an approximately USD 400 million... Read more







